Inflammasomes, potent inducers of IL-1β and IL-18 and pyroptosis, act as double-edged swords in cancers by producing tumor-promoting proinflammatory cytokines or facilitation of antitumor immune responses (Kolb et al., 2014). The gene discussed is IL18; the disease is cancer.